A detailed history of Ubs Group Ag transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ubs Group Ag holds 163,738 shares of JAZZ stock, worth $20.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
163,738
Previous 132,789 23.31%
Holding current value
$20.1 Million
Previous $14.2 Million 28.78%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $3.11 Million - $3.6 Million
30,949 Added 23.31%
163,738 $18.3 Million
Q2 2024

Aug 13, 2024

SELL
$103.94 - $118.98 $3.29 Million - $3.76 Million
-31,611 Reduced 19.23%
132,789 $14.2 Million
Q1 2024

May 13, 2024

SELL
$115.19 - $132.77 $984,528 - $1.13 Million
-8,547 Reduced 4.94%
164,400 $19.8 Million
Q4 2023

Feb 09, 2024

BUY
$114.26 - $136.0 $3.07 Million - $3.65 Million
26,844 Added 18.37%
172,947 $21.3 Million
Q3 2023

Nov 09, 2023

SELL
$122.0 - $145.31 $1.66 Million - $1.98 Million
-13,622 Reduced 8.53%
146,103 $18.9 Million
Q2 2023

Aug 11, 2023

SELL
$122.5 - $147.16 $1.71 Million - $2.06 Million
-13,972 Reduced 8.04%
159,725 $19.8 Million
Q1 2023

May 12, 2023

SELL
$133.98 - $160.47 $9.52 Million - $11.4 Million
-71,066 Reduced 29.03%
173,697 $25.4 Million
Q4 2022

Feb 08, 2023

BUY
$129.72 - $159.85 $10.9 Million - $13.5 Million
84,347 Added 52.58%
244,763 $39 Million
Q3 2022

Nov 10, 2022

BUY
$126.59 - $161.18 $827,898 - $1.05 Million
6,540 Added 4.25%
160,416 $21.4 Million
Q2 2022

Aug 10, 2022

SELL
$141.59 - $168.66 $2.15 Million - $2.56 Million
-15,198 Reduced 8.99%
153,876 $24 Million
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $1.84 Million - $2.28 Million
-14,173 Reduced 7.73%
169,074 $26.3 Million
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $396,410 - $481,730
-3,307 Reduced 1.77%
183,247 $23.3 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $1.17 Million - $1.68 Million
9,102 Added 5.13%
186,554 $24.3 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $7.28 Million - $8.47 Million
45,453 Added 34.43%
177,452 $31.5 Million
Q1 2021

May 12, 2021

SELL
$150.19 - $173.5 $5.4 Million - $6.23 Million
-35,925 Reduced 21.39%
131,999 $21.7 Million
Q4 2020

Feb 11, 2021

SELL
$140.71 - $165.05 $9.89 Million - $11.6 Million
-70,255 Reduced 29.5%
167,924 $27.7 Million
Q3 2020

Nov 12, 2020

SELL
$105.46 - $144.13 $1.24 Million - $1.69 Million
-11,756 Reduced 4.7%
238,179 $34 Million
Q2 2020

Jul 31, 2020

SELL
$95.68 - $121.88 $3.99 Million - $5.08 Million
-41,680 Reduced 14.29%
249,935 $27.6 Million
Q1 2020

May 01, 2020

BUY
$87.74 - $152.74 $2.03 Million - $3.54 Million
23,157 Added 8.63%
291,615 $29.1 Million
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $19.7 Million - $25.7 Million
-167,067 Reduced 38.36%
268,458 $40.1 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $791,513 - $905,706
6,323 Added 1.47%
435,525 $55.8 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $10.1 Million - $11.6 Million
-80,094 Reduced 15.73%
429,202 $61.2 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $14.6 Million - $17.1 Million
119,928 Added 30.8%
509,296 $72.8 Million
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $6.51 Million - $9.36 Million
-56,114 Reduced 12.6%
389,368 $48.3 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $6.78 Million - $7.61 Million
42,132 Added 10.45%
445,482 $74.9 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $3.45 Million - $4.31 Million
23,550 Added 6.2%
403,350 $69.5 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $1.39 Million - $1.61 Million
10,256 Added 2.78%
379,800 $57.3 Million
Q4 2017

Feb 14, 2018

BUY
$131.06 - $150.39 $9.06 Million - $10.4 Million
69,097 Added 23.0%
369,544 $49.8 Million
Q3 2017

Nov 14, 2017

SELL
$142.62 - $155.6 $1.88 Million - $2.05 Million
-13,185 Reduced 4.2%
300,447 $43.9 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-24,801 Reduced 7.33%
313,632 $48.8 Million
Q1 2017

Nov 14, 2017

BUY
N/A
338,433
338,433 $49.1 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.68B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.